著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Shifu Xiao and Piu Chan and Tao Wang and Zhen Hong and Shuzhen Wang and Weihong Kuang and Jincai He and Xiaoping Pan and Yuying Zhou and Yong Ji and Luning Wang and Yan Cheng and Ying Peng and Qinyong Ye and Xiaoping Wang and Yuncheng Wu and Qiumin Qu and Shengdi Chen and Shuhua Li and Wei Chen and Jun Xu and Dantao Peng and Zhongxin Zhao and Yansheng Li and Junjian Zhang and Yifeng Du and Weixian Chen and Dongsheng Fan and Yong Yan and Xiaowei Liu and Wei Zhang and Benyan Luo and Wenyuan Wu and Lu Shen and Chunfeng Liu and Peixian Mao and Qiumei Wang and Qianhua Zhao and Qihao Guo and Yongtao Zhou and Yi Li and Lijun Jiang and Wenwei Ren and Yingjun Ouyang and Yan Wang and Shuai Liu and Jianjun Jia and Nan Zhang and Zhonglin Liu and Raoli He and Tingyi Feng and Wenhui Lu and Huidong Tang and Ping Gao and Yingchun Zhang and Lanlan Chen and Lei Wang and You Yin and Qun Xu and Jinsong Xiao and Lin Cong and Xi Cheng and Hui Zhang and Dan Gao and Minghua Xia and Tenghong Lian and Guoping Peng and Xu Zhang and Bin Jiao and Hua Hu and Xueyan Chen and Yihui Guan and Ruixue Cui and Qiu Huang and Xianliang Xin and Hongjian Chen and Yu Ding and Jing Zhang and Teng Feng and Marc Cantillon and Kewei Chen and Jeffrey L. Cummings and Jian Ding and Meiyu Geng and Zhenxin Zhang,"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia",Alzheimer's Research & Therapy,1758-9193,Springer Science and Business Media LLC,2021-03-17,13,1,62,https://cir.nii.ac.jp/crid/1360576217205378048,https://doi.org/10.1186/s13195-021-00795-7